About us

Biograil™ was established in 2019 and is a pre-clinical stage pharmaceutical company leveraging its proprietary BIONDD™ technology to unlock the potential of transforming markets of injectable pharmaceutical products into convenient oral capsules.

Our Team

Karsten Lindhardt, CEO & Founder

Nikolaj Skak, CTO & Founder

Nils Piwon, Chief Development Officer

Martin Rex Olsen, Manufacturing Director

Lisbeth Nordly Lauritzen, PA

Nina Mertz, Industrial Postdoc

Kirsten Asser Larsen, Project Director

Lene Havsteen, Associated Director, Regulatory Affairs

Hanne Bruun Rasmussen, Sr. Laboratory Technician